Cabaletta Bio closes $100M public offering of 8.34M shares at $12.00/share

Cabaletta Bio, Inc.

Gross proceeds of approximately $100 million from sale of 8,337,500 shares, including full exercise of underwriters' option for 1,087,500 additional shares.
Price of shares was $12.00 per share, before underwriting discounts and commissions.
Joint book-running managers: TD Cowen, Evercore ISI, Guggenheim Securities; lead manager H.C. Wainwright & Co.
Company expects net proceeds plus existing cash to fund operations into Q4 2025.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.